PL2680833T3 - Pozajelitowe podawanie tapentadolu - Google Patents

Pozajelitowe podawanie tapentadolu

Info

Publication number
PL2680833T3
PL2680833T3 PL12709792T PL12709792T PL2680833T3 PL 2680833 T3 PL2680833 T3 PL 2680833T3 PL 12709792 T PL12709792 T PL 12709792T PL 12709792 T PL12709792 T PL 12709792T PL 2680833 T3 PL2680833 T3 PL 2680833T3
Authority
PL
Poland
Prior art keywords
tapentadol
parenteral administration
parenteral
administration
Prior art date
Application number
PL12709792T
Other languages
English (en)
Polish (pl)
Inventor
Thomas Christoph
Sabine Karine Katrien Inghelbrecht
Roger Carolus Augusta Embrechts
Ulrich Reinhold
Marc Schiller
Eva Wulsten
Klaus Schiene
Petra Bloms-Funke
Ulrich Feil
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of PL2680833T3 publication Critical patent/PL2680833T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL12709792T 2011-03-04 2012-03-02 Pozajelitowe podawanie tapentadolu PL2680833T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161449317P 2011-03-04 2011-03-04
EP11003602 2011-05-03
PCT/EP2012/000905 WO2012119728A1 (en) 2011-03-04 2012-03-02 Parenteral administration of tapentadol
EP12709792.1A EP2680833B1 (en) 2011-03-04 2012-03-02 Parenteral administration of tapentadol

Publications (1)

Publication Number Publication Date
PL2680833T3 true PL2680833T3 (pl) 2016-08-31

Family

ID=44653043

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12709792T PL2680833T3 (pl) 2011-03-04 2012-03-02 Pozajelitowe podawanie tapentadolu

Country Status (22)

Country Link
US (3) US20120225951A1 (cg-RX-API-DMAC7.html)
EP (2) EP2680833B1 (cg-RX-API-DMAC7.html)
JP (4) JP2014510067A (cg-RX-API-DMAC7.html)
KR (2) KR101970468B1 (cg-RX-API-DMAC7.html)
CN (2) CN103501775A (cg-RX-API-DMAC7.html)
AU (2) AU2012224953C1 (cg-RX-API-DMAC7.html)
BR (1) BR112013022213A2 (cg-RX-API-DMAC7.html)
CA (1) CA2828635C (cg-RX-API-DMAC7.html)
CY (1) CY1117426T1 (cg-RX-API-DMAC7.html)
DK (1) DK2680833T3 (cg-RX-API-DMAC7.html)
EA (2) EA024193B1 (cg-RX-API-DMAC7.html)
ES (1) ES2573414T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20160400T1 (cg-RX-API-DMAC7.html)
HU (1) HUE027514T2 (cg-RX-API-DMAC7.html)
IL (1) IL227825A (cg-RX-API-DMAC7.html)
MX (1) MX348831B (cg-RX-API-DMAC7.html)
PL (1) PL2680833T3 (cg-RX-API-DMAC7.html)
PT (1) PT2680833E (cg-RX-API-DMAC7.html)
RS (1) RS54711B1 (cg-RX-API-DMAC7.html)
SI (1) SI2680833T1 (cg-RX-API-DMAC7.html)
WO (1) WO2012119728A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201306479B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011267474B2 (en) 2010-06-15 2016-05-26 Grünenthal GmbH Pharmaceutical combination for the treatment of pain
LT3287123T (lt) 2011-03-04 2020-06-10 Grünenthal GmbH Vandeninė farmacinė tapentadolio kompozicija, skirta gerti
WO2013017233A1 (en) * 2011-07-29 2013-02-07 Grünenthal GmbH Intrathecal or epidural administration of 3-[(1s,2s)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol
EP2914243A1 (en) * 2012-11-01 2015-09-09 Torrent Pharmaceuticals Limited Pharmaceutical composition of tapentadol for parenteral administration
EP2808319A1 (en) 2013-05-31 2014-12-03 Arevipharma GmbH 3-[3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex
EP2845625A1 (en) 2013-09-04 2015-03-11 Grünenthal GmbH Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome
CN103735500B (zh) * 2014-01-28 2016-01-20 江苏华泽医药科技有限公司 盐酸他喷他多注射液及其制备方法
EA036258B1 (ru) * 2015-03-27 2020-10-20 Грюненталь Гмбх Стабильный препарат для парентерального введения тапентадола
WO2018055070A1 (en) * 2016-09-23 2018-03-29 Grünenthal GmbH Stable formulation for parenteral administration of tapentadol
WO2018153947A1 (en) 2017-02-23 2018-08-30 Grünenthal GmbH Tapentadol as local anesthetic
MX2021013888A (es) * 2019-05-16 2022-01-24 Nexus Pharmaceuticals Inc Composiciones que comprenden efedrina o una sal de efedrina y metodos de fabricacion y uso de las mismas.
EP4011369A1 (en) * 2020-12-14 2022-06-15 G.L. Pharma GmbH Aqueous pharmaceutical composition comprising tapentadol tartrate
CN114788814B (zh) * 2021-01-26 2023-10-13 浙江创新生物有限公司 一种高稳定性的注射用达托霉素组合物及其制备方法和其应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334422D0 (en) * 1983-12-23 1984-02-01 Sterwin Ag Composition
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
MXPA02010586A (es) * 2000-04-27 2003-03-10 Pfizer Prod Inc El uso de composiciones a base antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos.
WO2001089520A2 (en) * 2000-05-19 2001-11-29 Progenics Pharmaceuticals, Inc. Dehydroascorbic acid formulations and uses thereof
US6399087B1 (en) * 2000-12-20 2002-06-04 Amphastar Pharmaceuticals, Inc. Propofol formulation with enhanced microbial inhibition
DE10109763A1 (de) 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
JP4905616B2 (ja) * 2001-04-19 2012-03-28 ライオン株式会社 ソフトコンタクトレンズ用点眼剤
PE20030527A1 (es) 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
US20030191187A1 (en) * 2002-04-01 2003-10-09 Lee Fang Yu Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
US20040180915A1 (en) * 2003-03-14 2004-09-16 Xanodyne Pharmacal, Inc. Methadone-containing compositions for parenteral administration and method of use thereof
ATE368639T1 (de) * 2004-06-28 2007-08-15 Gruenenthal Gmbh Kristalline formen von (-)-(1r,2r)-3-(3- dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochlorid
WO2006002886A1 (de) 2004-07-01 2006-01-12 Grünenthal GmbH Gegen missbrauch gesicherte, orale darreichungsform enthaltend (1r, 2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
WO2006116626A2 (en) * 2005-04-28 2006-11-02 Theraquest Biosciences Llc Methods and compositions for treating pain
JP2009518315A (ja) * 2005-12-02 2009-05-07 エムディーアールエヌエー，インコーポレイテッド グルコース調節ペプチドの上皮透過性を増大させるための製剤処方
NZ571939A (en) 2006-04-28 2011-10-28 Gruenenthal Chemie Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and an NSAID
JP5496653B2 (ja) 2006-04-28 2014-05-21 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング ３−（３−ジメチルアミノ−１−エチル−２−メチル−プロピル）−フェノール、およびパラセタモールを含む医薬の組合せ
WO2008012283A1 (en) * 2006-07-24 2008-01-31 Janssen Pharmaceutica Nv Preparation of (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpentanamine
EP1905440A1 (de) * 2006-09-06 2008-04-02 Boehringer Ingelheim Pharma GmbH & Co. KG Verwendung einer pharmazeutischen Zusammensetzung enthaltend ein Anticholinergikum zur Abtötung von Mikroorganismen und zur Behandlung von Atemwegsinfektionen
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
DE102007012165A1 (de) * 2007-03-12 2008-09-18 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes
JP2008266168A (ja) * 2007-04-18 2008-11-06 Teika Seiyaku Kk 眼科用剤
EP1985292A1 (en) * 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
NZ586361A (en) 2007-11-23 2012-09-28 Gruenenthal Chemie Tapentadol compositions
EP2249811A1 (en) 2008-01-25 2010-11-17 Grünenthal GmbH Pharmaceutical dosage form
CN105520924B (zh) * 2008-09-05 2019-04-09 格吕伦塔尔有限公司 3-(3-二甲基氨基-1-乙基-2-甲基-丙基)-苯酚和抗癫痫药的联合药物
EP2246044A1 (en) * 2009-04-21 2010-11-03 Pierre Fabre Dermo-Cosmétique Paediatric solutions comprising a beta-blocker
US20100272815A1 (en) * 2009-04-28 2010-10-28 Actavis Group Ptc Ehf Amorphous form of tapentadol hydrochloride
CN101961315B (zh) * 2010-09-10 2012-09-05 海南美兰史克制药有限公司 一种门冬氨酸鸟氨酸脂质体注射液

Also Published As

Publication number Publication date
JP2022033863A (ja) 2022-03-02
EA201300990A1 (ru) 2014-02-28
JP6837944B2 (ja) 2021-03-03
BR112013022213A2 (pt) 2017-05-02
AU2012224953C1 (en) 2017-07-13
US20160106688A1 (en) 2016-04-21
MX348831B (es) 2017-06-30
ES2573414T3 (es) 2016-06-07
PT2680833E (pt) 2016-06-09
EP2680833B1 (en) 2016-03-02
JP2014510067A (ja) 2014-04-24
KR20140017587A (ko) 2014-02-11
CY1117426T1 (el) 2017-04-26
EA028149B1 (ru) 2017-10-31
CA2828635C (en) 2020-01-14
WO2012119728A1 (en) 2012-09-13
MX2013010046A (es) 2013-12-16
EA024193B1 (ru) 2016-08-31
US20120225951A1 (en) 2012-09-06
KR101970468B1 (ko) 2019-04-19
JP2023075244A (ja) 2023-05-30
AU2012224953A1 (en) 2013-09-19
CA2828635A1 (en) 2012-09-13
SI2680833T1 (sl) 2016-06-30
AU2017202214A1 (en) 2017-04-27
AU2012224953B2 (en) 2017-01-05
AU2017202214B2 (en) 2019-02-14
EP3025710A1 (en) 2016-06-01
HUE027514T2 (en) 2016-10-28
RS54711B1 (sr) 2016-08-31
IL227825A (en) 2017-07-31
KR101903351B1 (ko) 2018-10-04
HK1194964A1 (zh) 2014-10-31
IL227825A0 (en) 2013-09-30
EP2680833A1 (en) 2014-01-08
CN107088226A (zh) 2017-08-25
KR20180064568A (ko) 2018-06-14
CN103501775A (zh) 2014-01-08
DK2680833T3 (en) 2016-05-23
EA201600088A1 (ru) 2016-07-29
JP2018021050A (ja) 2018-02-08
ZA201306479B (en) 2014-05-28
US20200215003A1 (en) 2020-07-09
HRP20160400T1 (hr) 2016-05-20

Similar Documents

Publication Publication Date Title
ZA201306479B (en) parenteral administration of tapentadol
HUE047354T2 (hu) Ivacaftor deuterizált származékai
SI3235812T1 (sl) Devterirani derivati ivakaftorja
LT2675480T (lt) Konjugatų gavimo būdai
EP2774512A4 (en) SEAT
EP2774511A4 (en) CHAIR
ZA201401012B (en) Parenteral novovirus vaccine formulations
EP2662268A4 (en) CAP MOUNTING STRUCTURE
SG10201604667YA (en) Pharmaceutical preparation
SI2672973T1 (sl) Režim dajanja nitrokaterolov
IL229591A0 (en) Addition of medicine
GB201105298D0 (en) Pharmaceutical preparation
EP2741751A4 (en) CONCENTRATED FELBAMATE FORMULATIONS FOR PARENTERAL ADMINISTRATION
EP2756374A4 (en) AUTOBIOGRAPHIC INTERFACE
PT2694049T (pt) Tapentadol para prevenir a cronicidade da dor
EP2684869A4 (en) PREPARATION OF 3-MERCAPOTOPROPIONATES
PL2691119T3 (pl) Preparat farmaceutyczny
SG11201402471SA (en) Photocatalyst-supporting structure
GB2488222B (en) Chair
PL395425A1 (pl) Sposób wytwarzania chlorowodorku 2-amino-N-tert-butylo-2- cyjanoacetamidu
TWM432265U (en) Improved structure of connection member
GB201109614D0 (en) Odontalgic preparation
GB201121362D0 (en) Drapery hardware
GB201119948D0 (en) Corben chair 001-103
PH32011001045S1 (en) Chair